natgillin/translations-raw huggingface dataset:
If you forget to take your insulin your blood sugar may get too high (hyperglycaemia). 
Ako ste zaboravili primijeniti inzulin razina šećera u krvi može biti previsoka (hiperglikemija).
The prolonged action of Levemir is mediated by the strong self-association of insulin detemir molecules at the injection site and albumin binding via the fatty acid side-chain. 
Produljeno djelovanje lijeka Levemir posljedica je jakog međusobnog vezanja molekula detemir inzulina na mjestu injiciranja te vezanja za albumin putem postraničnog lanca masnih kiselina.
Levemir can be used in adolescents and children aged 1 year and above. 
Levemir se može koristiti u adolescenata i djece u dobi od 1 ili više godina.
Mean HbA1c (%) at GW 36 
Prosječni HbA1c (%) u
Injecting your dose Make sure that you receive your full dose by using the right injection technique. 
Kako biste bili sigurni da ste primili cijelu dozu inzulina, primijenite pravilnu tehniku injiciranja.
The blood glucose lowering effect of Levemir is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver. 
Učinak lijeka Levemir na snižavanje razine glukoze u krvi posljedica je olakšanog ulaska glukoze nakon vezanja inzulina na receptore na mišićnim i masnim stanicama te istovremene inhibicije otpuštanja glukoze iz jetre.
K. Remove the needle from the skin. 
Izvadite iglu iz kože.
These reactions include pain, redness, hives, inflammation, bruising, swelling and itching at the injection site. 
Te reakcije uključuju bol, crvenilo, koprivnjaču, upalu, modrice, oticanje i svrbež na mjestu injiciranja.
Common - Injection site reactions 
Često - reakcije na mjestu injiciranja
Levemir should not be added to infusion fluids. 
Levemir se ne smije dodavati u infuzijske tekućine.
• Always make sure that a drop appears at the needle tip before injection (picture B). 
• Prije injiciranja uvijek provjerite je li se na vrhu igle pojavila kapljica (slika B).
Levemir was studied in an open-label randomised controlled clinical trial, pregnant women with type 1 diabetes (n=310) were treated in a basal-bolus treatment regimen with Levemir (n=152) or NPH insulin (n=158) as basal insulin, both in combination with NovoRapid (see section 4.6). 
Levemir je ispitan u otvorenom, randomiziranom, kontroliranom kliničkom ispitivanju, u kojemu su trudnice koje imaju šećernu bolest tipa 1 (n=310) liječene bazal-bolus terapijom u kojoj su Levemir (n=152) ili NPH inzulin (n=158) primjenjivani kao bazalni inzulin i u oba slučaja kombinirani s lijekom NovoRapid (vidjeti dio 4.6).
Studies in patients with type 2 diabetes treated with basal insulin in combination with oral antidiabetic medicinal products demonstrated that glycaemic control (HbA1c) with Levemir is comparable to NPH insulin and insulin glargine and associated with less weight gain, see Table 2 below. 
Ispitivanja u bolesnika sa šećernom bolešću tipa 2 liječenih bazalnim inzulinom u kombinaciji s oralnim antidijabeticima pokazala su da je regulacija glikemije (HbA1c) s lijekom Levemir usporediva s NPH inzulinom i glargin inzulinom te povezana s manjim porastom tjelesne težine, vidjeti Tablicu 2
LIST OF EXCIPIENTS glycerol, phenol, metacresol, zinc acetate, disodium phosphate dihydrate, sodium chloride, hydrochloric acid/sodium hydroxide for pH adjustment and water for injections 
glicerol, fenol, metakrezol, cinkov acetat, natrijev hidrogenfosfat dihidrat, natrijev klorid, kloridnu kiselinu/natrijev hidroksid za podešavanje pH i vodu za injekcije.
1 ml solution contains 100 units insulin detemir (equivalent to 14.2 mg). 
1 ml otopine sadrži 100 jedinica detemir inzulina (što odgovara 14,2 mg).
The most frequently reported adverse reaction is hypoglycaemia. 
Hipoglikemija Hipoglikemija je najčešće prijavljivana nuspojava.
Levemir is for injection under the skin (subcutaneously). 
Levemir je namijenjen injiciranju pod kožu (supkutano).
► If the insulin does not appear water clear, colourless and aqueous. 
► ako inzulin nije bistar, bezbojan i voden.
During use or when carried as a spare: Levemir InnoLet that is being used or carried as a spare should not be kept in the refrigerator. 
Tijekom uporabe ili kada lijek nosite kao rezervni: Levemir InnoLet koji koristite ili nosite kao rezervni ne smijete odlagati u hladnjak.
Insulins and analogues for injection, long-acting: ATC code: A10AE05. 
ATK oznaka: A10AE05.
• Remove the paper tab from a new disposable needle. 
• Otrgnite papirnati pokrov s nove igle za jednokratnu uporabu.
Your InnoLet is a simple, compact pre-filled pen able to deliver 1 to 50 units in increments of 1 unit. 
InnoLet je jednostavna, kompaktna napunjena brizgalica, kojom se odmjeravanjem po 1 jedinice, mogu birati doze u rasponu od 1 do 50 jedinica.
Levemir provides up to 24 hours of basal insulin coverage. 
Levemir pokriva bazalne potrebe za inzulinom do 24 sata.
Clinical trial data - Levemir add-on to liraglutide+metformin Study week Randomised 
Tablica 3: Podaci iz kliničkog ispitivanja - Levemir kao dodatak uz liraglutid+metformin
There was no clinically relevant difference in pharmacokinetics of Levemir between patients with renal or hepatic impairment and healthy subjects. 
Nisu utvrđene klinički značajne razlike u farmakokinetici lijeka Levemir između bolesnika s oštećenjem bubrega ili jetre i zdravih ispitanika.
Dose proportionality in serum concentrations (maximum concentration, extent of absorption) is observed after subcutaneous administration in the therapeutic dose range. 
Nakon supkutane primjene doza u terapijskom rasponu, koncentracije u serumu (maksimalna koncentracija, stupanj apsorpcije) proporcionalne su dozi.
Dispose of it carefully and put the pen cap back on your FlexPen. 
Pažljivo bacite iglu u otpad i vratite zatvarač na brizgalicu FlexPen.
Levemir is presented as a solution for injection. 
Levemir je otopina za injekciju.
In clinical trials using basal bolus insulin therapy, the overall rates of hypoglycaemia with Levemir and NPH insulin were similar. 
U kliničkim ispitivanjima u kojima su ispitanici liječeni bazal-bolus inzulinskom terapijom, ukupne stope hipoglikemije bile su slične uz Levemir i NPH inzulin.
Zinc acetate 
Metakrezol Cinkov acetat
+3 units 
+3 jedinice
• Caregivers must be very careful when handling used needles -to reduce the risk of needle injury and cross-infection. 
• Osobe koje skrbe za bolesnika moraju biti vrlo oprezne pri rukovanju rabljenim iglama kako bi smanjile rizik od uboda iglom i prijenosa infekcije.
• Always carry an extra pen and new needles with you, in case of loss or damaged. 
• Uvijek sa sobom nosite rezervnu brizgalicu i nove igle za slučaj da izgubite ili oštetite onu koju trenutno koristite.
The safety and efficacy of Levemir in children below the age of 1 year have not been established. 
Sigurnost i djelotvornost lijeka Levemir u djece mlađe od 1 godine nisu ustanovljene.
Always watch the dose counter to know how many units you inject. 
Uvijek gledajte brojčanik doze kako biste znali koliko ste jedinica injicirali.
MARKETING AUTHORISATION NUMBER EU/1/04/278/014 
12. BROJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/04/278/014
Allergic reactions, potentially allergic reactions, urticaria, rash, eruptions Allergic reactions, potentially allergic reactions, urticaria, rash and eruptions are uncommon when Levemir is used in basal-bolus regimen. 
Alergijske reakcije, potencijalno alergijske reakcije, urtikarija, osip i erupcije javljaju se manje često kad se Levemir primjenjuje u sklopu bazal-bolus terapije.
Can be stored in a refrigerator (2°C-8°C). 
Može se čuvati u hladnjaku (2°C-8°C).
Preparing your Levemir FlexTouch pen Check the name and coloured label on your Levemir FlexTouch pen to make sure that it contains the type of insulin you need. 
Provjerite naziv i boju naljepnice na Vašoj Levemir FlexTouch brizgalici kako biste bili sigurni da sadrži vrstu inzulina koju trebate.
In long-term trials in patients with type 1 diabetes receiving a basal-bolus insulin therapy, fasting plasma glucose was improved with Levemir compared with NPH insulin. 
U dugotrajnim ispitivanjima u bolesnika sa šećernom bolešću tipa 1 koji su bili na bazal-bolus inzulinskoj terapiji, razina glukoze u plazmi natašte poboljšana je uz Levemir u odnosu na NPH inzulin.
► Levemir Penfill cartridges are designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles. 
► Levemir Penfill ulošci namijenjeni su uporabi s pomagalima za primjenu inzulina proizvođača Novo Nordisk i iglama NovoFine ili NovoTwist.
• Always check that the push-button is fully depressed and the dose selector is set to 0. 
Odmjeravanje doze • Uvijek provjerite je li potisni gumb pritisnut do kraja, a izbornik doze postavljen na 0.
They may include cold sweats, cool pale skin, fatigue, nervousness or tremor, anxiousness, unusual tiredness or weakness, confusion, difficulty in concentrating, drowsiness, excessive hunger, vision changes, headache, nausea and palpitation. 
Simptomi hipoglikemije obično se javljaju naglo, a mogu uključivati: hladan znoj, hladnu blijedu kožu, umor, nervozu ili tremor, anksioznost, neuobičajen umor ili slabost, konfuznost, poteškoće s koncentracijom, omamljenost, izrazitu glad, promjene vida, glavobolju, mučninu i palpitacije.
Less weight gain (SD score, weight corrected for gender and age) was observed with Levemir than with NPH insulin. 
Uz Levemir je zabilježen manji porast tjelesne težine (SD vrijednost, težina prilagođena s obzirom na spol i dob) u odnosu na NPH inzulin.
There was no clinically relevant difference in pharmacokinetics of Levemir between elderly and young patients. 
Nisu utvrđene klinički značajne razlike u farmakokinetici lijeka Levemir između starijih i mladih bolesnika.
There are no clinically relevant differences between genders in pharmacokinetic properties of Levemir. 
Spol Nisu utvrđene klinički značajne razlike u farmakokinetičkim svojstvima lijeka Levemir između spolova.
Activity profiles of Levemir in patients with type 1 diabetes 
Slika 1: Profili djelovanja lijeka Levemir u bolesnika sa šećernom bolešću tipa 1
HbA1c ≤6% targets at both GW 24 and GW 
Udio bolesnica koje su postigle ciljne vrijednosti HbA1c ≤ 6% i u 24. i u 36.
0-26 weeks 0.286 0-52 weeks 0.228 
0-26 tjedana 0,286 0-52 tjedna 0,228
Levemir is a long-acting insulin analogue used as a basal insulin. 
Levemir je dugodjelujući inzulinski analog koji se koristi kao bazalni inzulin.
During use or when carried as a spare: You can carry your Levemir FlexPen with you and keep it at a temperature below 30°C or in a refrigerator (2°C to 8°C) for up to 6 weeks. 
Tijekom uporabe ili kada lijek nosite kao rezervni: Levemir FlexPen možete nositi sa sobom i čuvati na temperaturi ispod 30°C ili u hladnjaku (2°C do 8°C) do 6 tjedana.
• Sympathomimetics (such as epinephrine [adrenaline], or salbutamol, terbutaline used to treat asthma) 
• simpatomimetike (poput epinefrina [adrenalina] ili salbutamola, terbutalina koji se koriste za liječenje astme) • hormon rasta (lijek za stimulaciju rasta kostiju i tkiva s izraženim utjecajem na metaboličke procese u tijelu)
Fast improvement in blood glucose control may be associated with acute painful neuropathy, which is usually reversible. 
Naglo poboljšanje regulacije glikemije može biti povezano s akutnom bolnom neuropatijom,
Levemir Penfill 3 ml solution in cartridge (type 1 glass) with a plunger (bromobutyl) and a rubber closure 
3 ml otopine u ulošku (staklo tipa 1) s klipom (brombutil) i gumenim zatvaračem (brombutil/poliizopren).
During use or when carried as a spare: You can carry your Levemir FlexTouch with you and keep it at a temperature below 30°C or in a refrigerator (2°C to 8°C) for up to 6 weeks. 
Tijekom uporabe ili kada lijek nosite kao rezervni: Levemir FlexTouch možete nositi sa sobom i čuvati na temperaturi ispod 30°C ili u hladnjaku (2°C do 8°C) do 6 tjedana.
Levemir Penfill is designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles. 
Levemir Penfill namijenjen je uporabi s pomagalima za primjenu inzulina proizvođača Novo Nordisk i iglama NovoFine ili NovoTwist.
A major hypoglycaemic episode is defined as an episode where the subject was not able to treat him/herself and if glucagon or i.v. 
Teškom epizodom hipoglikemije smatrala se ona u kojoj si ispitanik nije mogao sam pomoći i ako je bilo potrebno primijeniti glukagon ili glukozu i.v.; vidjeti Tablicu 3.
Each cartridge contains 300 units of insulin detemir in 3 ml solution for injection. 
Jedan uložak sadrži 300 jedinica detemir inzulina u 3 ml otopine za injekciju.
• At the request of the European Medicines Agency 
Ažurirani RMP treba dostaviti: • na zahtjev Europske agencije za lijekove;
For patients who require twice daily dosing to optimise blood glucose control, the evening dose can be administered in the evening or at bedtime. 
U bolesnika kojima je za optimalnu regulaciju glikemije potrebno doziranje dva puta dnevno, večernja se doza može primijeniti navečer ili prije odlaska na spavanje.
Levemir contains less than 1 mmol sodium (23 mg) per dose, i.e. Levemir is essentially ‘sodium-free'. 
Važne informacije o nekim sastojcima lijeka Levemir Levemir sadrži manje od 1 mmol (23 mg) natrija po dozi, tj.
Based on post-marketing sources and clinical trials, the frequency, type and severity of adverse reactions observed in elderly patients and in patients with renal or hepatic impairment do not indicate any differences to the broader experience in the general population. 
vrsta i ozbiljnost nuspojava opaženih u starijih bolesnika i bolesnika s oštećenjem bubrega ili jetre ne upućuju na razlike u odnosu na šire iskustvo u općoj populaciji.
0-26 weeks 43.1 0-52 weeks 51.9 
0-26 tjedna 43,1 0-52 tjedna 51,9
Use the dose selector on your Levemir FlexTouch pen to select your dose. 
Odaberite svoju dozu uz pomoć izbornika doze na Vašoj Levemir FlexTouch brizgalici.
Subsequently, dosage should be adjusted individually. 
Nakon toga doziranje treba prilagoditi individualnim potrebama.
The absolute bioavailability of insulin detemir when administered subcutaneous is approximately 
Apsolutna bioraspoloživost detemir inzulina kod supkutane primjene iznosi otprilike 60%.
Each pre-filled pen contains 300 units of insulin detemir in 3 ml solution for injection. 
Jedna napunjena brizgalica sadrži 300 jedinica detemir inzulina u 3 ml otopine za injekciju.
When turning the dose selector be careful not to push the pushbutton as insulin will come out. 
Pazite da ne pritisnete potisni gumb kad okrećete izbornik doze jer će inzulin tada iscuriti.
On rare occasions, injection site reactions may require discontinuation of Levemir. 
Zbog reakcija na mjestu injiciranja rijetko će biti potrebno prekinuti liječenje lijekom Levemir.
Pack sizes of 1 (with or without needles), 5 (without needles) or a multipack with 2 x 5 (without needles) pre-filled pens of 3 ml. 
Veličine pakiranja: 1 (sa ili bez igala), 5 (bez igala) ili višestruko pakiranje od 2 x 5 (bez igala)
6.6 Special precautions for disposal and other handling Do not use this medicinal product if you notice that the solution is not clear, colourless and aqueous. 
Nemojte primjenjivati ovaj lijek ako primijetite da otopina nije bistra, bezbojna i vodena.
Concomitant diseases in the kidney, liver or affecting the adrenal, pituitary or thyroid gland can require changes in insulin dose. 
Popratne bolesti bubrega, jetre ili one koje zahvaćaju nadbubrežnu žlijezdu, hipofizu ili štitnjaču mogu uvjetovati promjenu doze inzulina.
Novo Nordisk Production SAS 45, Avenue d'Orléans F-28000 Chartres France 
Ako su druga i treća oznaka H7 ili T6, proizvođač je Novo Nordisk Production SAS, 45 Avenue d'Orléans, F-28000 Chartres, Francuska.
If you take too much insulin your blood sugar gets too low (hypoglycaemia). 
Ako primijenite previše inzulina previše će se sniziti razina šećera u krvi (hipoglikemija).
-4 units 
- 4 jedinice
Getting started 
Vidjeti i
• your doctor has added another medicine for the treatment of diabetes, in addition to your 
• je liječnik uz liječenje lijekom Levemir dodao još jedan lijek za liječenje šećerne bolesti.
Maternal glycaemic control Levemir NPH Difference/ Odds Ratio/ Rate Ratio 95% CI 
Levemir NPH Razlika/Omjer vjerojatnosti/
The trials demonstrated that glycaemic control (HbA1c) with Levemir is comparable to NPH insulin and insulin degludec when given as basal-bolus therapy, using a noninferiority margin of 0.4%. 
Sva su ispitivanja pokazala da je regulacija glikemije (HbA1c) uz Levemir usporediva s NPH inzulinom i degludek inzulinom kada se daju u sklopu bazal-bolus terapije,
When a GLP-1 receptor agonist is added to Levemir, it is recommended to reduce the dose of Levemir by 20% to minimise the risk of hypoglycaemia. 
Kad se agonist GLP-1 receptora dodaje lijeku Levemir, preporučuje se smanjiti dozu lijeka Levemir za
In children and adolescents, glucose monitoring should be intensified and the Levemir dose adjusted on an individual basis. 
U djece i adolescenata treba pojačano pratiti razine glukoze te individualno prilagoditi dozu lijeka
Caregivers must be very careful when handling used needles -to reduce the risk of needle sticks and cross-infection. 
Osobe koje skrbe za bolesnika moraju biti vrlo oprezne pri rukovanju rabljenim iglama kako bi smanjile rizik od uboda iglom i prijenosa infekcije.
-3 units 
-3 jedinice
In trials investigating the use of oral antidiabetic medicinal products, combination therapy with Levemir resulted in a 61-65% lower risk of minor nocturnal hypoglycaemia compared to NPH insulin. 
Levemir smanjila je rizik od lakših noćnih hipoglikemija za 61-65% u usporedbi s NPH inzulinom.
Levemir has a long and steady blood-sugar-lowering action within 3 to 4 hours after injection. 
Levemir ima dugo i ravnomjerno djelovanje na snižavanje razine šećera u krvi, koje nastupa unutar
When Levemir is used in combination with oral antidiabetic medicinal products or when added to GLP-1 receptor agonists it is recommended to use Levemir once daily, initially at a dose of 0.10.2 units/kg or of 10 units in adult patients. 
receptora, preporučuje se primijeniti Levemir jednom dnevno, u početnoj dozi od 0,1-0,2 jedinica/kg ili 10 jedinica u odraslih bolesnika.
Levemir InnoLet is a pre-filled disposable pen containing insulin detemir. 
Levemir InnoLet je jednokratna napunjena brizgalica koja sadrži detemir inzulin.
In patients with renal or hepatic impairment, glucose monitoring should be intensified and the Levemir dose adjusted on an individual basis. 
U bolesnika s oštećenjem bubrega ili jetre treba pojačano pratiti razine glukoze te individualno prilagoditi dozu lijeka Levemir.
Instructions on how to use Levemir 100 units/ml solution for injection in pre-filled pen (FlexTouch) 
Upute za uporabu Levemir 100 jedinica/ml otopine za injekciju u napunjenoj brizgalici (FlexTouch)
If no drop appears, you will not inject any insulin, even though the dose counter may move. 
Ako se kapljica ne pojavi, nećete injicirati nimalo inzulina, čak i ako se brojčanik doze pomiče.
0-26 weeks -0.16 0-52 weeks -0.05 
0-26 tjedana -0,16 0-52 tjedna -0,05
The dose of Levemir should be titrated based on the individual patient's needs. 
Dozu lijeka Levemir treba titrirati sukladno potrebama pojedinog bolesnika.
0-26 weeks -0.51 0-52 weeks -0.50 
0-26 tjedana -0,51 0-52 tjedna -0,50
In elderly patients, glucose monitoring should be intensified and the Levemir dose adjusted on an individual basis. 
U starijih bolesnika treba pojačano pratiti razine glukoze te individualno prilagoditi dozu lijeka Levemir.
Dose selector Pushbutton 
Izbornik doze Potisni gumb
When administered twice daily, steady state serum concentrations are reached after 2-3 dose administrations. 
Kod primjene dva puta dnevno, koncentracije u serumu u stanju dinamičke ravnoteže postižu se nakon primjene
Levemir FlexTouch is designed to be used with NovoFine or NovoTwist single-use disposable needles up to a length of 8 mm. 
Levemir FlexTouch namijenjen je za uporabu s jednokratnim iglama NovoFine ili NovoTwist, duljine do 8 mm.
*Self-Monitored Plasma Glucose Adult type 2 diabetes simple self-titration guideline: Average pre-breakfast SMPG* 
Smjernice za titraciju u odraslih bolesnika koji imaju šećernu bolest tipa 2: Prosječne vrijednosti SMGP* prije doručka
Levemir is for subcutaneous administration only. 
Levemir je namijenjen samo za supkutanu primjenu.
5 x 3 ml pre-filled pens 2 x (5 x 3 ml) pre-filled pens 1 x 3 ml pre-filled pen + 7 NovoFine needles 1 x 3 ml pre-filled pen + 7 NovoTwist needles 
1 x 3 ml napunjena brizgalica 5 x 3 ml napunjenih brizgalica 2 x (5 x 3 ml) napunjenih brizgalica 1 x 3 ml napunjena brizgalica + 7 NovoFine igala 1 x 3 ml napunjena brizgalica + 7 NovoTwist igala
► If you are allergic to insulin detemir or any of the other ingredients in this medicine, see section 
Što morate znati prije nego počnete primjenjivati Levemir Nemojte primjenjivati Levemir ► ako ste alergični na detemir inzulin ili neki drugi sastojak ovog lijeka, vidjeti dio 6. Sadržaj pakiranja i druge informacije.
EU/1/04/278/004 1 pen of 3 ml EU/1/04/278/005 5 pens of 3 ml EU/1/04/278/006 10 pens of 3 ml EU/1/04/278/010 1 pen of 3 ml and 7 NovoFine needles EU/1/04/278/011 1 pen of 3 ml and 7 NovoTwist needles 
EU/1/04/278/004 1 brizgalica od 3 ml EU/1/04/278/005 5 brizgalica od 3 ml EU/1/04/278/006 10 brizgalica od 3 ml EU/1/04/278/010 1 brizgalica od 3 ml i 7 NovoFine igala
Do not use this medicine after the expiry date which is stated on the FlexTouch label and carton after ‘EXP'. 
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na naljepnici uloška i kutiji iza oznake ‘Rok valjanosti'.
Drinking alcohol and taking Levemir 
Konzumiranje alkohola i primjena lijeka Levemir
Rate Ratio: 
Omjer stopa:
Levemir treatment. 
NAČIN PRIMJENE LIJEKA
Before using Levemir 
Prije primjene lijeka Levemir
EU/1/04/278/015 1 pen of 3 ml and 7 NovoFine needles EU/1/04/278/016 1 pen of 3 ml and 7 NovoTwist needles 
EU/1/04/278/015 1 brizgalica od 3 ml i 7 NovoFine igala EU/1/04/278/016 1 brizgalica od 3 ml i 7 NovoTwist igala
F. Turn the dose selector to select 2 units. 
• Okrenite izbornik doze u smjeru kazaljke na satu kako biste odabrali 2 jedinice.
The best places to give yourself an injection are: the front of your thighs, the front of your waist (abdomen), or the upper arm. You should always measure your blood sugar regularly. 
Najbolja mjesta za injiciranje su prednja strana bedara, područje trbuha (abdomen) ili nadlaktice.
Levemir is a soluble, long-acting insulin analogue with a prolonged duration of effect used as a basal insulin. 
Levemir je topiv, dugodjelujući inzulinski analog s produljenim djelovanjem koji se primjenjuje kao bazalni inzulin.
EU/1/04/278/014 5 pens of 3 ml. 
EU/1/04/278/014 5 brizgalica od 3 ml.
Levemir Penfill is only suitable for subcutaneous injections from a reusable pen. 
Levemir Penfill je prikladan samo za potkožne injekcije iz brizgalice za višekratnu uporabu.
Dose and when to take your insulin 
Kako primjenjivati Levemir Doza i kada trebate primijeniti inzulin
► Needles and Levemir InnoLet must not be shared. 
► Igle i Levemir InnoLet ne smiju se dijeliti s drugim osobama.
Pen cap Paper tab 
Papirnati pokrov
Levemir FlexPen is a pre-filled, colour-coded, disposable pen containing insulin detemir. 
Levemir FlexPen je jednokratna napunjena brizgalica označena bojom, koja sadrži detemir inzulin.
► Needles and Levemir Penfill must not be shared. 
► Igle i Levemir Penfill ne smiju se dijeliti s drugim osobama.
Now turn over for information on how to use your FlexTouch. 
Okrenite stranicu radi informacija o uporabi brizgalice FlexTouch.
► Levemir Penfill is only suitable for injecting under the skin using a reusable pen. 
► Levemir Penfill je prikladan samo za ubrizgavanje pod kožu pomoću brizgalice za višekratnu uporabu.
Your Levemir FlexTouch pen is a pre-filled insulin pen Levemir FlexTouch contains 300 units of insulin and delivers doses from 1 to 80 units, in increments of 1 unit. 
Levemir FlexTouch sadrži 300 jedinica inzulina, a odmjeravanjem po 1 jedinice mogu se birati doze u rasponu od 1 do 80 jedinica.
B Remove the paper tab from a new disposable needle. 
Otrgnite papirnati pokrov s nove igle za jednokratnu uporabu.